| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |